市场调查报告书
商品编码
1503382
到 2030 年远距病患监护市场预测 - 按产品(穿戴式装置、行动装置、远距医疗、远距监护装置和其他产品)、服务、应用、最终用户和地理位置进行全球分析Remote Patient Monitoring Market Forecasts to 2030 - Global Analysis By Product (Wearable Devices, Mobile Devices, Telehealth, Remote Monitoring Devices and Other Products), Service, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球远距病患监护市场规模为 725.2 亿美元,预计到 2030 年将达到 2,105.6 亿美元,预测期内复合年增长率为 25.6%。远端患者监测是一种医疗保健技术,可让医疗专业人员在传统临床环境之外监测患者。它利用数位设备即时收集患者的医疗资料,例如生命征象、症状和其他健康指标。这些资讯被安全地传输给医疗保健提供者,从而在必要时实现持续监控和主动干预。 RPM 透过促进健康问题的早期发现、提高治疗依从性和减少频繁去医院的需要来增强病患照护。
根据美国疾病管制与预防中心 (CDC) 的数据,美国有超过 1 亿人患有高血压,美国心臟协会 (AHA) 支持旨在增加远距患者监测技术 (RPM) 使用范围的倡议,以改善健康状况管理。
慢性病盛行率增加
全球糖尿病、心血管疾病和呼吸系统疾病等慢性病的盛行率不断上升,对传统医疗保健环境之外的持续监测和管理提出了更大的需求,从而推动了远端患者监测(RPM) 的增长。 RPM 可远端即时监测生命征象、症状和健康参数,及早发现恶化的健康状况并及时介入。这种积极主动的方法不仅可以改善患者的治疗效果,还可以降低与可预防的住院和急诊室就诊相关的医疗费用,使 RPM 成为慢性病管理策略的重要工具。
有限的报销政策
远端病患监测 (RPM) 中有限的报销政策通常源于建立标准化报销框架的挑战,该框架考虑了可用的各种 RPM 服务和技术。这些政策在不同地区和付款人之间存在很大差异,导致 RPM 服务覆盖范围存在不确定性和不一致。缺乏明确和全面的报销可能会阻碍医疗保健提供者和组织投资 RPM 解决方案,从而减缓市场采用和创新。
老年人口不断增加
随着老年人口的增加,慢性病和与年龄相关的健康问题的盛行率也在增加,需要持续监测和管理。 RPM 技术使医疗保健提供者能够远端监控生命体征、用药依从性和整体健康状况,从而促进早期干预和个人化护理。这种能力不仅可以改善老年人的健康状况,还可以透过减少频繁就诊和住院的需要来提高他们的生活质量,从而有效且经济高效地应对人口老龄化的挑战。
技术壁垒
远端病患监护的技术障碍包括不同设备和系统之间的连接性、互通性以及确保资料安全和隐私问题。这些障碍会阻碍无缝资料传输和即时监控,影响 RPM 解决方案的可靠性和有效性。此外,新技术的使用者接受度和可用性问题可能会降低医疗保健提供者和患者的采用率。
Covid-19 影响
由于医疗保健提供者力求最大限度地减少亲自就诊并降低暴露风险,Covid-19 大流行极大地推动了远距患者监测市场。 RPM 的采用率激增,因为它能够远端监控 COVID-19 患者的生命迹象和症状。这增加了对 RPM 解决方案的需求,推动了市场成长和创新。它还强调了 RPM 在危机期间管理医疗保健服务方面的潜力,从而扩大了大流行病之外的应用范围。
预计穿戴式装置市场在预测期内将是最大的市场
穿戴式装置领域预计将出现利润丰厚的成长。穿戴式装置透过持续追踪心率、血压和活动水平等生命体征,在远端患者监测中发挥关键作用。它们使医疗保健提供者能够即时远端监控患者的健康状况,及早发现异常情况,并在必要时及时进行干预。这些设备透过提供数据驱动的健康趋势洞察并促进个人化治疗计划来增强患者护理,最终改善结果并降低医疗成本。
慢性病管理服务领域预计在预测期内复合年增长率最高
预计慢性病管理服务领域在预测期内将出现最快的复合年增长率。远端患者监测涉及从远处持续追踪患者的健康资料,从而增强主动护理。这种方法利用穿戴式装置和行动应用程式等数位技术来远端监测生命征象和症状。医疗保健提供者可以及早期干预,减少住院并改善患者的治疗结果。这是现代医疗保健中一种很有前景的策略,可以有效管理糖尿病、高血压和心臟病等疾病。
在亚太地区,由于医疗保健支出增加、慢性病盛行率上升以及医疗保健技术进步,远距病患监护市场正在经历大幅成长。由于老年人口数量不断增加以及对高效医疗保健管理的需求,日本、中国、印度和澳洲等国家正在大量采用 RPM 解决方案。政府推广数位健康解决方案的措施进一步推动市场扩张。随着持续的技术进步和医疗改革,亚太地区的市场有望持续成长。
在北美,远距患者监护市场强劲且迅速扩张。由于先进的医疗基础设施、有利的报销政策以及糖尿病和心血管疾病等慢性病的高盛行率,该地区在 RPM 采用方面处于全球领先地位。在医疗保健成本增加和转向基于价值的护理模式的推动下,美国和加拿大是市场成长的主要贡献者。该市场的特点是创新,技术和监管框架的不断发展支持其成长。
2024 年 1 月,班加罗尔着名的多专科医院 Apollo Hospital 宣布与领先的人工智慧健康监测技术公司 LifeSigns 建立开创性合作伙伴关係。标誌着精准医疗和主动病患管理的重大进步。
2023 年 5 月,飞利浦推出了虚拟护理管理,这是一个由灵活的解决方案和服务组成的综合产品组合,为医疗系统、提供者、付款人和雇主提供激励,并与任何地方的患者互动。
According to Stratistics MRC, the Global Remote Patient Monitoring Market is accounted for $72.52 billion in 2024 and is expected to reach $210.56 billion by 2030 growing at a CAGR of 25.6% during the forecast period. Remote patient monitoring is a healthcare technology that allows medical professionals to monitor patients outside of conventional clinical settings. It utilizes digital devices to collect medical data, such as vital signs, symptoms, and other health indicators, from patients in real-time. This information is transmitted securely to healthcare providers, enabling continuous monitoring and proactive intervention when necessary. RPM enhances patient care by facilitating early detection of health issues, improving treatment adherence, and reducing the need for frequent hospital visits.
According to the Centers for Disease Control and Prevention (CDC), over 100 million people have hypertension in the United States and The American Heart Association (AHA) supports initiatives that increase access to the use of Remote Patient Monitoring technologies (RPM) for better health management.
Increasing prevalence of chronic diseases
The increasing prevalence of chronic diseases globally, such as diabetes, cardiovascular diseases, and respiratory conditions, drives the growth of the remote patient monitoring (RPM) by creating a greater demand for continuous monitoring and management outside traditional healthcare settings. RPM allows for real-time monitoring of vital signs, symptoms, and health parameters remotely, enabling early detection of deteriorating health conditions and timely intervention. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with preventable hospitalizations and emergency room visits, making RPM an essential tool in chronic disease management strategies.
Limited reimbursement policies
Limited reimbursement policies in remote patient monitoring (RPM) often stem from challenges in establishing standardized reimbursement frameworks that account for the diverse RPM services and technologies available. These policies vary widely across regions and payers, leading to uncertainty and inconsistency in coverage for RPM services. This lack of clear and comprehensive reimbursement can deter healthcare providers and organizations from investing in RPM solutions, slowing market adoption and innovation.
Growing elderly population
As the elderly population increases, so does the prevalence of chronic conditions and age-related health issues requiring continuous monitoring and management. RPM technology allows healthcare providers to remotely monitor vital signs, medication adherence, and overall health status, facilitating early intervention and personalized care. This capability not only improves health outcomes for seniors but also enhances their quality of life by reducing the need for frequent clinic visits and hospitalizations, thereby addressing the challenges of aging populations efficiently and cost-effectively.
Technological barriers
Technological barriers in remote patient monitoring include issues with connectivity, interoperability between different devices and systems, and ensuring data security and privacy. These barriers can hinder seamless data transmission and real-time monitoring, impacting the reliability and effectiveness of RPM solutions. Moreover, user acceptance and usability issues with new technologies can slow adoption rates among healthcare providers and patients alike.
Covid-19 Impact
The covid-19 pandemic significantly boosted the remote patient monitoring market as healthcare providers sought to minimize in-person visits and reduce exposure risks. RPM adoption surged due to its ability to remotely monitor COVID-19 patients' vital signs and symptoms. This increased demand for RPM solutions, driving market growth and innovation. It also highlighted RPM's potential in managing healthcare delivery during crises, leading to expanded applications beyond the pandemic.
The wearable devices segment is expected to be the largest during the forecast period
The wearable devices segment is estimated to have a lucrative growth. Wearable devices play a pivotal role in remote patient monitoring by continuously tracking vital signs like heart rate, blood pressure, and activity levels. They enable healthcare providers to remotely monitor patients' health in real-time, detect anomalies early, and intervene promptly when necessary. These devices enhance patient care by providing data-driven insights into health trends and facilitating personalized treatment plans, ultimately improving outcomes and reducing healthcare costs.
The chronic disease management services segment is expected to have the highest CAGR during the forecast period
The chronic disease management services segment is anticipated to witness the fastest CAGR growth during the forecast period. Remote patient monitoring involves continuous tracking of patients' health data from a distance, enhancing proactive care. This approach utilizes digital technologies like wearable devices and mobile apps to monitor vital signs and symptoms remotely. Healthcare providers can intervene early, reducing hospitalizations and improving patient outcomes. It's a promising strategy in modern healthcare for managing conditions such as diabetes, hypertension, and heart disease efficiently.
In the Asia Pacific region, the remote patient monitoring market is experiencing substantial growth driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and advancements in healthcare technology. Countries like Japan, China, India, and Australia are witnessing significant adoption of RPM solutions due to expanding elderly populations and the need for efficient healthcare management. Government initiatives promoting digital health solutions further propel market expansion. The market in Asia Pacific is poised for continued growth with ongoing technological advancements and healthcare reforms.
In North America, the remote patient monitoring market is robust and rapidly expanding. The region leads globally in RPM adoption due to advanced healthcare infrastructure, favourable reimbursement policies, and a high prevalence of chronic diseases such as diabetes and cardiovascular conditions. The United States and Canada are key contributors to market growth, driven by increasing healthcare costs and the shift towards value-based care models. The market is characterized by innovation, with ongoing developments in technology and regulatory frameworks supporting its growth.
Key players in the market
Some of the key players profiled in the Remote Patient Monitoring Market include Philips Healthcare, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Apollo, Omron Healthcare, GE Healthcare, Honeywell Life Care Solutions, Biotricity Inc., iRhythm Technologies, Smiths Medical, Resideo Life Care Solutions, Masimo Corporation, Qualcomm Life and Garmin Health.
In January 2024, Apollo Hospital, a renowned multi-specialty hospital in Bangalore, announces a pioneering partnership with LifeSigns, a leading AI-powered health monitoring technology company.This collaboration empowers the hospital with a cutting-edge 24/7 wireless and remote patient monitoring system, marking a significant advancement in precision healthcare and proactive patient management.
In May 2023, Philips launched Virtual Care Management, a comprehensive portfolio of flexible solutions and services health systems, providers, payers, and employers to motivate and engage with patients from anywhere.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.